Evaluating effects of Cyproheptadine and Folic acid in children with ADHD receiving Ritali
Phase 3
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD).Disturbance of activity and attention
- Registration Number
- IRCT201203167462N5
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Age range of 7-12; ADHD combined form; Clinical need to treat with Methylphenidate; parental consent and child ascent Exclusion criteria: any confounding co-morbiditis; any drug supplements or narcotics consumption; Children with history of major prenatal complications such as prematurity, low birth weight (reported by parents), any past or present psychosis, comorbid tourette syndrome, celiac, phenylketonuria, autism, or other persistent developmental disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attention deficiency score and Hyperactivity score. Timepoint: 0-2-4-8 weeks. Method of measurement: ADHD rating scale for children (complited by parents).;Appetite score. Timepoint: 0-2-4-8 weeks. Method of measurement: Standard appetite questionnaire for chilldren.;Sleep disorders score. Timepoint: 0-2-4-8 weeks. Method of measurement: Sleep disorders scale for chilldren (SDSC).
- Secondary Outcome Measures
Name Time Method Stimulants side effects. Timepoint: week 8. Method of measurement: Stimulants side effects questionnare.